By
30 min ago 2 min read
UK-based electrolyser maker CPH2 has halted testing of its 1MW membrane-free electrolyser after an error triggered a standard shutdown procedure, causing damage during the system’s final testing stages.
The start-up has already suspended trading on the London Stock Exchange’s Alternative Investment Market.
Testing remains paused pending an investigation into the error and system failure, in line with health, safety and environmental processes.
CPH2, which is reviewing insurance options and assessing implications of the incident, will delay its factory acceptance test (FAT), previously expected during May.
Jon Duffy, CPH2 CEO, called the incident a “disappointing outcome,” adding that work towards resolving the technical issue will begin immediately.
This is a breaking news story, H2 View will update this page shortly.
Gain access to the insights, data, and analysis trusted by hydrogen professionals worldwide.
With a H2 View subscription, you get:
- Unlimited access to 15,000+ articles
- Monthly digital magazine + H2 Review
- Exclusive interviews, webinars and reports
- Expert analysis shaping the hydrogen conversation
